1 Citation (Scopus)
12 Downloads (Pure)


Gliomas are primary malignant brain tumors with poor survival and high resistance to available treatments. Improving the molecular understanding of glioma and disclosing novel biomarkers of tumor development and progression could help to find novel targeted therapies for this type of cancer. Public databases such as The Cancer Genome Atlas (TCGA) provide an invaluable source of molecular information on cancer tissues. Machine learning tools show promise in dealing with the high dimension of omics data and extracting relevant information from it. In this work, network inference and clustering methods, namely Joint Graphical lasso and Robust Sparse K-means Clustering, were applied to RNA-sequencing data from TCGA glioma patients to identify shared and distinct gene networks among different types of glioma (glioblastoma, astrocytoma, and oligodendroglioma) and disclose new patient groups and the relevant genes behind groups’ separation. The results obtained suggest that astrocytoma and oligodendroglioma have more similarities compared with glioblastoma, highlighting the molecular differences between glioblastoma and the others glioma subtypes. After a comprehensive literature search on the relevant genes pointed our from our analysis, we identified potential candidates for biomarkers of glioma. Further molecular validation of these genes is encouraged to understand their potential role in diagnosis and in the design of novel therapies.
Original languageEnglish
Article number26
Number of pages16
JournalBioData Mining
Issue number1
Publication statusPublished - Dec 2023


  • Biomarkers
  • Glioma
  • Joint graphical lasso
  • Robust sparse K-means clustering
  • Sparse networks
  • Transcriptomics


Dive into the research topics of 'Disclosing transcriptomics network-based signatures of glioma heterogeneity using sparse methods'. Together they form a unique fingerprint.

Cite this